S0413 Lapatinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer

Summary

This phase II trial is studying how well lapatinib works in treating patients with locally advanced or metastatic stomach cancer. Lapatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth

Timeline

Start

2004-12

Primary completion

2007-05

Completion

—

Drugs

Indications